CENTRAL NERVOUS SYSTEM LESION side effect
What is CENTRAL NERVOUS SYSTEM LESION ?Drugs associated with CENTRAL NERVOUS SYSTEM LESION
BETASERON CARBAMAZEPINE COPAXONE DALTEPARIN DURAGESIC FABRAZYME LIPITOR METHOTREXATE NAGLAZYME NEORAL REBIF REMICADECENTRAL NERVOUS SYSTEM LESION : Duragesic Side Effects Report #5669094-X
Physician from UNITED STATES reported DURAGESIC problem on Mar 10, 2008. Female patient, 55 years of age, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, cerebral haemorrhage, haemangioma, migraine, . DURAGESIC dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Rebif Side Effects Report #5616918-8
REBIF problem was reported by a Physician from SLOVENIA on Jan 18, 2008. Female patient, 32 years of age, weighting 136.7 lb, was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Fabrazyme Side Effects Report #5625166-7
Physician from GERMANY reported FABRAZYME problem on Jan 25, 2008. Female patient, 43 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, cerebral infarction, . FABRAZYME dosage: unknown. During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Dalteparin Side Effects Report #5639070-1
DALTEPARIN problem was reported by a Physician from CZECH REPUBLIC on Feb 11, 2008. Female patient, 24 years of age, was diagnosed with cerebral venous thrombosis and was treated with DALTEPARIN. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, coma, condition aggravated, . DALTEPARIN dosage: unknown. During the same period patient was treated with PROGESTERONE, ANTIBIOTICS. Patient was hospitalized. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Fabrazyme Side Effects Report #5646798-6
Physician from GERMANY reported FABRAZYME problem on Feb 14, 2008. Female patient, 43 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, cerebral infarction, cerebrovascular accident, sudden hearing loss, tinnitus, . FABRAZYME dosage: 70 MG, Q2W, INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Copaxone Side Effects Report #5633746-8
COPAXONE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, optic neuritis, . COPAXONE dosage: 20 MG, SUBCUTANEOUS. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Copaxone Side Effects Report #5633766-3
Health Professional from UNITED STATES reported COPAXONE problem on Feb 01, 2007. Female patient, child 10 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, . COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Remicade Side Effects Report #5541455-9
REMICADE problem was reported by a Physician from SPAIN on Nov 29, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, hemiparesis, . REMICADE dosage: unknown. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Remicade Side Effects Report #5545574-2
Physician from SPAIN reported REMICADE problem on Nov 30, 2007. Female patient, 49 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, hemiparesis, tuberculosis skin test positive, . REMICADE dosage: unknown. During the same period patient was treated with DACORTIN, METHOTREXATE, CEMIDON. Patient was hospitalized. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Betaseron Side Effects Report #5450409-2
BETASERON problem was reported by a Health Professional from UNITED STATES on Aug 31, 2007. Female patient, 57 years of age, weighting 170.0 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, cervical myelopathy, chills, injection site bruising, . BETASERON dosage: unknown. During the same period patient was treated with KEPPRA, TOPROL, NORVASC, LASIX, LUNESTA. Patient was hospitalized. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Remicade Side Effects Report #5413469-0
Consumer or non-health professional from UNITED STATES reported REMICADE problem on Aug 03, 2007. Female patient, weighting 155.0 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, grand mal convulsion, pneumonia aspiration, type 2 diabetes mellitus, . REMICADE dosage: unknown. During the same period patient was treated with ASPIRIN, METHOTREXATE, LIPITOR, ATIVAN, ZOLOFT, LOPRESSOR, ANALAPRIL, LYRICA. Patient was hospitalized. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Fabrazyme Side Effects Report #5671586-4
FABRAZYME problem was reported by a Physician from GERMANY on Mar 06, 2008. Female patient, 43 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: amnesia, central nervous system lesion, cerebral infarction, cerebrovascular accident, sudden hearing loss, tinnitus, . FABRAZYME dosage: 70 MG, Q2W, INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Naglazyme Side Effects Report #5613391-0
Physician from BRAZIL reported NAGLAZYME problem on Jan 11, 2008. Male patient, child 7 years of age, weighting 32.19 lb, was diagnosed with mucopolysaccharidosis vi and was treated with NAGLAZYME. After drug was administered, patient experienced the following problems/side effects: abasia, central nervous system lesion, clonus, condition aggravated, csf protein increased, hyperreflexia, hypotonia, meningeal disorder, muscle spasticity, . NAGLAZYME dosage: 1.5 ML;QM;INTH, 15 MG;X1;IV. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Betaseron Side Effects Report #5409001-8
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2007. Female patient, 61 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: asthenia, central nervous system lesion, memory impairment, nervous system disorder, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Lipitor Side Effects Report #5618772-7
Physician from UNITED STATES reported LIPITOR problem on Jan 30, 2008. Male patient, weighting 129.0 lb, was diagnosed with blood cholesterol, hyperlipidaemia, back pain and was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, central nervous system infection, central nervous system lesion, headache, ill-defined disorder, mobility decreased, nervous system disorder, parasite blood test positive, pyrexia, . LIPITOR dosage: unknown. During the same period patient was treated with LYRICA, PREDNISONE, ACIPHEX, PERCOCET, OLIVE OIL, FISH OIL. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Lipitor Side Effects Report #5587179-3
LIPITOR problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 31, 2007. Male patient, weighting 129.0 lb, was diagnosed with blood cholesterol, back pain and was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, central nervous system infection, central nervous system lesion, headache, ill-defined disorder, mobility decreased, nervous system disorder, parasite blood test positive, pyrexia, . LIPITOR dosage: unknown. During the same period patient was treated with LYRICA, PREDNISONE, ACIPHEX, PERCOCET, OLIVE OIL, FISH OIL. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Neoral Side Effects Report #5515754-0
Consumer or non-health professional from CANADA reported NEORAL problem on Nov 06, 2007. Male patient, 62 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cardiac arrest, central nervous system lesion, chills, confusional state, convulsion, faecal incontinence, heart rate irregular, hypotension, . NEORAL dosage: 200 MG/DAILY. Patient was hospitalized. Patient died on 08/04/2007.
CENTRAL NERVOUS SYSTEM LESION : Carbamazepine Side Effects Report #5490616-6
CARBAMAZEPINE problem was reported by a Health Professional from SPAIN on Sept 19, 2007. Female patient, 24 years of age, was diagnosed with partial seizures and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: amnesia, apraxia, central nervous system lesion, dysarthria, motor dysfunction, partial seizures, . CARBAMAZEPINE dosage: 800 MG/DAY. Patient was hospitalized. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Methotrexate Side Effects Report #5500077-6
Consumer or non-health professional from GERMANY reported METHOTREXATE problem on Oct 09, 2007. Male patient, child 7 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: areflexia, arthralgia, central nervous system lesion, dysuria, femur fracture, leukaemia recurrent, meningism, monoparesis, neurotoxicity, . METHOTREXATE dosage: unknown. During the same period patient was treated with CYTARABINE, PREDNISOLONE. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Carbamazepine Side Effects Report #5369843-4
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from JAPAN on June 05, 2007. Male patient, 46 years of age, was diagnosed with agitation and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, catatonia, central nervous system lesion, diabetes insipidus, nuclear magnetic resonance imaging brain abnormal, stupor, . CARBAMAZEPINE dosage: 600 MG, 1X/DAY:QD. During the same period patient was treated with LITHIUM CARBONATE, PROMETHAZINE, FLUNITRAZEPAM, BULOTIZOLAM, NIMETAZEPAM, OXATAMIDE. Patient was hospitalized. Patient recovered.
CENTRAL NERVOUS SYSTEM LESION : Carbamazepine Side Effects Report #5369843-4
Consumer or non-health professional from JAPAN reported CARBAMAZEPINE problem on June 05, 2007. Male patient, 46 years of age, was diagnosed with agitation and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, catatonia, central nervous system lesion, diabetes insipidus, nuclear magnetic resonance imaging brain abnormal, stupor, . CARBAMAZEPINE dosage: 600 MG, 1X/DAY:QD. During the same period patient was treated with LITHIUM CARBONATE, PROMETHAZINE, FLUNITRAZEPAM, BULOTIZOLAM, NIMETAZEPAM, OXATAMIDE. Patient was hospitalized. Patient recovered.